Medifast MED Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $385.79M-36.0% | $602.46M-43.8% | $1.07B-32.9% | $1.6B+4.7% | ||
| $110.6M-29.9% | $157.84M-46.7% | $296.2M-35.3% | $458.16M+15.0% | ||
| $275.19M-38.1% | $444.62M-42.7% | $775.85M-32.0% | $1.14B+1.1% | ||
| 71.3%-2.5pp | 73.8%+1.4pp | 72.4%+1.0pp | 71.3%-2.5pp | ||
| $289.4M-34.5% | $441.74M-32.0% | $649.45M-32.0% | $955.61M+4.9% | ||
| -$14.21M-594% | $2.88M-97.7% | $126.4M-31.6% | $184.81M-14.5% | ||
| -3.7%-4.2pp | 0.5%-11.3pp | 11.8%+0.2pp | 11.6%-2.6pp | ||
| $8.57M+843% | $909K-62.0% | $2.4M+420% | -$748K-568% | ||
| -$5.64M-249% | $3.79M-97.1% | $128.8M-30.0% | $184.06M-14.8% | ||
| $13.03M+669% | $1.7M-94.2% | $29.38M-27.4% | $40.49M-22.3% | ||
| -$18.67M-993% | $2.09M-97.9% | $99.41M-30.8% | $143.57M-12.5% | ||
| -4.8%-5.2pp | 0.3%-8.9pp | 9.3%+0.3pp | 9%-1.8pp | ||
| -$1.71-1,050% | $0.18-98.0% | $9.11-28.3% | $12.71-8.5% | ||
| $30K-99.8% | $15.59M-88.8% | $139.51M-28.7% | $195.79M-12.2% | ||
| 0%-2.6pp | 2.6%-10.4pp | 13%+0.8pp | 12.2%-2.4pp | ||
| -$14.21M-594% | $2.88M-97.7% | $126.4M-31.6% | $184.81M-14.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Medifast's revenue?
- Medifast (MED) generated $346.1M in revenue over the trailing twelve months, down 36.3% year over year.
- Is Medifast profitable?
- Medifast is not currently profitable: it reported a net loss of $20.0M over the trailing twelve months, a -5.8% net margin.
- What are Medifast's profit margins?
- Gross margin is 70.1% and operating margin is -4.7%, with a -5.8% net margin.
- What is Medifast's earnings per share?
- Medifast's diluted EPS over the trailing twelve months is $-1.83.
- Where does Medifast's income statement data come from?
- Every line is extracted from Medifast's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
